These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Estramustine phosphate (Estracyt) in the treatment of prostatic carcinoma.
    Author: Könyves I.
    Journal: Int Urol Nephrol; 1989; 21(4):393-7. PubMed ID: 2693392.
    Abstract:
    This review presents the most important hormonal, cytotoxic and pharmacokinetic properties of estramustine phosphate. Furthermore the results of randomized Phase III trials are described in patients with hormone refractory prostatic cancer with and without previous irradiation. Several randomized studies are reported with Estracyt also in the primary treatment of this disease.
    [Abstract] [Full Text] [Related] [New Search]